Board Meeting Details

  • Date: Friday, 14th August, 2026
  • Location: Registered office of the Company
  • Purpose: To transact the following businesses:
  • Augment financial resources via funds raising through issue of equity shares/convertible instruments/other securities
  • Methods considered: preferential allotment, right issue, QIP's, ADR GDR, FCCB or any other method or combination thereof
  • May be conducted in one or more trenches
  • Consider and approve Standalone Unaudited Financial Results for quarter ended 30th June 2026
  • Consider any other matter with permission of the Chair

Trading Window Closure

  • Trading window for designated persons and their immediate relatives has been closed since 01st July, 2026
  • Closure will remain in effect until 48 hours after declaration of Standalone Un-audited Financial Results for quarter ended 30th June, 2026
  • Closure implemented as per SEBI (Prohibition of Insider Trading) Regulation, 2015 and Company's Code of Conduct